Is TapImmune’s cancer vaccine the real deal?
A small study testing a cancer vaccine by a company who licensed the technology from the Mayo Clinic showed promising results in breast and ovarian cancer.
Mayo Clinic to license vaccine technology to Seattle startup
Mayo Clinic is partnering with a Seattle-based biotech startup to develop vaccines against breast cancer and smallpox, the company said. TapImmune Inc. (OTCBB:TPIV) said it reached a deal to license Mayo technology that will help the company develop a vaccine that it says can prompt the body's immune system to mount an aggressive attack on the diseases.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.